NCT06435065View on ClinicalTrials.gov

Direct Pulp Capping Agent on Human Pulp Tissue

PHASE4RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

June 30, 2024

Study Completion Date

July 31, 2024

Conditions
Reversible Pulpitis
Interventions
DRUG

Biodentine

DIRECT PULP CAPPINGWILL BE DONE USING BIODENTINE

DRUG

Mineral Tri-Oxide Aggregate

DIRECT PULP CAPPINGWILL BE DONE USING MTA

DRUG

THERACAL LC

DIRECT PULP CAPPINGWILL BE DONE USING THERACAL LC

DRUG

TRISTRONTIUM ALUMINATE

DIRECT PULP CAPPINGWILL BE DONE USING TRISTRONTIUM ALUMINATE

Trial Locations (1)

133207

RECRUITING

Swati, Ambāla

All Listed Sponsors
lead

DR SURINDER SACHDEVA

OTHER